A model of BCR-FGFR1 driven human AML in immunocompromised mice

Benzer Materyaller

• Development of ZMYM2-FGFR1 driven AML in human CD34+ cells in immunocompromised mice
  Yazar:: Ren, Mingqiang, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinase
  Yazar:: Hu, Tianxiang, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Dysregulated signaling pathways in the development of CNTRL-FGFR1–induced myeloid and lymphoid malignancies associated with FGFR1 in human and mouse models
  Yazar:: Ren, Mingqiang, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Loss of the BCR-FGFR1 GEF domain suppresses RHOA activation and enhances B-lymphomagenesis in mice.
  Yazar:: Hu, Tianxiang, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Targeting FGFR1 to suppress leukemogenesis in syndromic and de novo AML in murine models
  Yazar:: Wu, Qing, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)